EP Patent

EP2257326A2 — Powder dispersion apparatus

Assigned to Novartis AG · Expires 2010-12-08 · 15y expired

What this patent protects

Methods and apparatuses for the pulmonary delivery of a composition, such as methods and apparatuses for dispersing dry powder medicaments for inhalation by a patient. Elements or aspects of the apparatuses, including receptacle puncturing mechanisms (H), deoccluding devices (G),…

USPTO Abstract

Methods and apparatuses for the pulmonary delivery of a composition, such as methods and apparatuses for dispersing dry powder medicaments for inhalation by a patient. Elements or aspects of the apparatuses, including receptacle puncturing mechanisms (H), deoccluding devices (G), receptacle impacting devices (N), and receptacle lock devices (M) or systems.

Drugs covered by this patent

Patent Metadata

Patent number
EP2257326A2
Jurisdiction
EP
Classification
—
Expires
2010-12-08
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.